The low affinity receptor for IgG, Fc␥RII (CD32), has a wide distribution on hematopoietic cells where it is responsible for a diverse range of cellular responses crucial for immune regulation and resistance to infection. Fc␥RII is a member of the immunoglobulin superfamily, containing an extracellular region of two Ig-like domains. Cell surface receptors for the Fc portion of IgG (Fc␥R) are expressed on most hematopoietic cells, and through the binding of IgG they play a key role in homeostasis of the immune system and host protection against infection. Three structurally related but functionally distinct classes of Fc␥R have been defined: Fc␥RI, Fc␥RII, and Fc␥RIII (1-3). Fc␥RII is a low affinity receptor for IgG that binds only IgG immune complexes and is expressed on a diverse range of cells such as monocytes, macrophages, neutrophils, eosinophils, platelets, and B cells (1-3). Fc␥RII is involved in a number of immune responses including antibody-dependent cell-mediated cytotoxicity, clearance of immune complexes, release of inflammatory mediators, and regulation of antibody production (1-6).The extracellular region of Fc␥RII comprises two Ig-like disulfide-bonded extracellular domains that are related to the Ig superfamily proteins and are most closely related to the C2 set of Ig domains (7-12). The two Ig-like domain extracellular region of Fc␥RII is structurally conserved in all of the Ig superfamily leukocyte FcRs (including Fc␥RI, Fc␥RIII, Fc⑀RI, and Fc␣RI) and presumably represents an Ig-interactive motif (13-17). The elucidation of the molecular basis of FcR-Ig interactions is fundamental for understanding the mechanisms by which these receptors mediate biological functions such as activation of inflammatory cells, induction of cytokine release, and destruction of pathogens. In previous studies we utilized chimeric Fc receptors to identify the IgG binding region of human Fc␥RII (18,19 (20). However, despite the direct demonstration of only a single region involved in the binding of IgG, there is compelling evidence to suggest that other regions of Fc␥RII contribute to binding. A genetic polymorphism of human Fc␥RIIa, the so called "responder/non-responder" system, results in an amino acid substitution in domain 2 at residue 131 (Arg 3 His), which has been shown to influence the binding of mouse . Similarly, in the mouse a genetic polymorphism of Fc␥RII, identified as differences at residues 116 and 161, defines the epitope of the anti-Ly17.2 mAb 1 that blocks the binding of IgG to this receptor (24, 25). Our previous molecular modeling studies of Fc␥RII domain 2 (wherein the Asn 154 -Ser 161 binding region was located to an exposed loop region; the F/G loop) suggest that these functionally important amino acid changes are situated in the B/C and CЈ/E loops (containing residues 116 and 131, respectively), which are juxtaposed to the F/G loop (contains residue 161) at or near the interface with domain 1 (20). Furthermore, the studies using chimeric Fc␥RII/Fc⑀RI receptors have identified three regions i...